Solventum (SOLV) Stock Price & Analysis

SOLV$89.08+0.27 +0.30%
Medical - Instruments & SuppliesLarge Cap
Compare
Market cap$15.14BEnterprise value$20.13BRevenue (TTM)$8.16BMarket positionTop 25%

Score

32
Bearish
Value
29
Quality
53
Growth
15

AI Analysis

Snapshot

Solventum doesn’t screen as a clean setup today — Stocklytics 32/100 leaves more to prove. Under the hood: P/E 101.2, rich vs its own history.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

29
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

15
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

53
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Solventum Corporation (SOLV) last printed $89.08. Equity value is $15.14B. Trailing earnings multiple 97.05. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

202020212022202320242025
$7.28B$8.17B$8.13B$8.2B$8.25B$8.32B

About

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Solventum (SOLV) Stock Price & Analysis

SOLV price $89.08 +0.27 +0.30%

Ticker
SOLV
Price
$89.08
Change
+0.27 +0.30%
Market cap
$15.14B
P/E
97.05
Forward P/E
12.00
Dividend yield
0.00%
Beta
0.75
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
32
Value
29
Quality
53
Growth
15

Stocklytics score rationale: value 29, quality 53, growth 15.

AI Score 75. Solventum Corporation has a market cap of approximately $15.2 billion and a price-to-earnings ratio of about 10.87, indicating a potentially attractive valuation. However, its negative free cash flow and high debt levels, with a debt-to-equity ratio of 1.10, raise concerns about financial stability despite strong revenue growth in recent quarters

Insights · Forecast · Financials · Learn

Stocklytics home · Screener